Lannett Company, Inc.

About

“With three facilities in Philadelphia, PA, Lannett Company, Inc. manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Our portfolio consists of numerous products across a wide range of therapeutic areas. We believe that our ability to select viable products for development, efficiently develop such products, including obtaining any applicable regulatory approvals, vertically integrate ourselves into certain specialty markets and achieve economies in production are all critical for our success in the generic pharmaceutical industry in which we operate. Having cultivated strong and dependable customer relationships by maintaining adequate inventory levels and demonstrating a responsive order filling system, we take pride in our ability to satisfy our customer’s needs. Our dedicated employees strive to position Lannett as an industry leader that is focused on quality and integrity, as well as giving back to the community we serve. Lannett has a history of supporting schools, hospitals, veterans and their families, institutions, rehabilitation centers, cancer research, as well as the local fire and police departments”.-LinkedIn

Industry
Pharmaceuticals
Company size
1,001-5,000 employees
Headquarters
Philadelphia, Pennsylvania
Type
Public Company
Founded
1942

“Founded in 1942, Lannett Company, Inc. is a leading manufacturer of over 100 unique pharmaceutical product families that save and enhance people’s lives. We are a US-based company, with our headquarters in Philadelphia, PA, and top-notch facilities for research and development, manufacturing, packaging, business, and distribution in four states including Pennsylvania, Indiana, New York, and Wyoming”. Website

BDC Credit Reporter View

4/16/2019: With the latest news on State of Connecticut fines and that negative article on SA, we’ve downgraded Lannett from CCR 3 to CCR 4. That means we expect that in its ultimate resolution the investment is more likely than not to result in some material Realized Loss. An interruption of income may occur relatively quickly if the Company does file for bankruptcy protection.